首页 › 囊性纤维化 › 俄亥俄州 › Cincinnati
Cincinnati OH 囊性纤维化临床试验
10项针对 囊性纤维化的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Sinus Disease in Young Children With Cystic Fibrosis
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
招募中观察性研究欢迎健康志愿者
- University of Cincinnati, Cincinnati
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
招募中
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
招募中4 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati Medical Center, Cincinnati
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Regional Monitoring of CF Lung Disease
招募中早期 I 期
- Cincinnati Children's Hospital, Cincinnati
Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
招募中
- CCHMC, Cincinnati
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Regional Phenotyping of CF and Non-CF Bronchiectasis
招募中观察性研究欢迎健康志愿者
- Penny New, Cincinnati
其他城市的 囊性纤维化试验
- Boston, MA17 项研究
- Birmingham, AL16 项研究
- Philadelphia, PA15 项研究
- Kansas City, KS13 项研究
- Seattle, WA12 项研究
- Baltimore, MD12 项研究
- Denver, CO11 项研究
- Dallas, TX11 项研究
- Pittsburgh, PA11 项研究
- Los Angeles, CA9 项研究
- Aurora, CO9 项研究
- Charleston, SC8 项研究
Cincinnati的其他研究
- 非小细胞肺癌35 项研究
- 癌症(所有类型)27 项研究
- 乳腺癌25 项研究
- 心力衰竭24 项研究
- 结直肠癌21 项研究
- 转移性癌症21 项研究
- 急性髓系白血病20 项研究
- 卵巢癌19 项研究
- 肥胖症19 项研究
- 肺癌19 项研究
- 前列腺癌18 项研究
- 黑色素瘤17 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。